Pulmatrix, Inc. (PULM) - NASDAQ
Company Description
Pulmatrix, Inc. engages as a biopharmaceutical company, which develops inhaled therapies to address serious pulmonary disease. It develops a proprietary dry powder technology called iSPERSE, which is used for the treatment of serious pulmonary diseases. Its pipeline of products consists of... More
Sector: Healthcare
Industry: Biotechnology
Country: United States